| Date Filed | Type | Description |
| 08/25/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/25/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/16/2022 |
8-K
| Quarterly results |
| 08/05/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 06/23/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/23/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/23/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/23/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/28/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/15/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 04/06/2022 |
4
| Singer William S. (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 1,500 options to buy
@ $7.41, valued at
$11.1k
|
|
| 04/06/2022 |
4
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 1,500 options to buy
@ $7.41, valued at
$11.1k
|
|
| 04/06/2022 |
4
| SCHECHTER JONATHAN (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 1,500 options to buy
@ $7.41, valued at
$11.1k
|
|
| 04/06/2022 |
4
| Bernstein Bruce (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 1,500 options to buy
@ $7.41, valued at
$11.1k
|
|
| 03/29/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2022 |
SC 13G/A
| HAYWOOD GEORGE WEAVER reports a 7% stake in Synaptogenix, Inc. |
| 01/31/2022 |
SC 13G/A
| ALPHA CAPITAL ANSTALT reports a 4.5% stake in SYNAPTOGENIX, INC. |
| 11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 10/01/2021 |
8-K
| Quarterly results |
| 08/13/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/13/2021 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 07/16/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/15/2021 |
4
| TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 60,000 shares
@ $0 |
|
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Perry George (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 07/15/2021 |
4
| SCHECHTER JONATHAN (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 45,000 shares
@ $0 |
|
| 07/15/2021 |
4
| WEINSTEIN ROBERT (CFO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 60,000 shares
@ $0 |
|
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 90,000 shares
@ $0 |
|
| 07/07/2021 |
SC 13G
| ALPHA CAPITAL ANSTALT reports a 5.5% stake in SYNAPTOGENIX, INC. |
|